Cincinnati-based Enable Injections is a global healthcare innovation company developing and manufacturing drug delivery systems designed to improve the patient experience. Enable’s body-worn enFuse® delivers high-volume (5-25 mL) pharmaceutical and biologic therapeutics via subcutaneous administration, with the aim of improving convenience, supporting superior outcomes, and advancing healthcare system economics. For more information, please visit www.enableinjections.com.

Evonik Industries, a global leader in specialty chemicals, provides drug delivery technologies, API manufacturing, intermediates, ingredients for nutraceuticals, amino acids and derivatives. Drug delivery technologies include modified release formulation development services, solubility enhancement, functional excipients, bioresorbable polymers, lipid nanoparticle mRNA delivery, and GMP manufacturing for oral and parenteral formulations. Advanced delivery technologies for extended-release parenterals are offered for small molecules, peptides, proteins, antibodies, and nucleic acids. Learn more about us at www.evonik.com/healthcare.

Flex is the manufacturing partner of choice that helps a diverse customer base design and build products that improve the world. Through the collective strength of a global workforce across 30 countries and responsible, sustainable operations, Flex delivers technology innovation, supply chain, and manufacturing solutions to diverse industries and end markets. Flex’s health solutions business focuses on medical device and drug delivery design, development and manufacturing solutions for pharmaceutical and medtech companies, including extensive work in injection pens, autoinjectors, wearable pumps and smart inhalers. Our approach is supported by FDA-registered and ISO 13485 compliant and ISO 11608-1 accredited facilities, with a world-class single quality system across sites. For more information, visit www.flex.com

Harro Höfliger specializes in the development of customer-oriented process and production solutions for pharmaceutical and medical applications as well as market-oriented consumer products. In addition to innovative machine platforms and packaging machines, customized turnkey system solutions for product assembly, processing of web materials, as well as dosing and inhalation technology are the company’s core expertise. The systematically structured portfolio of upscalable test machines and modules, as well as requirement-oriented technology platforms, results from many years of experience and targeted research and development. Thus, Harro Höfliger covers all phases from the laboratory stage to high-performance production. For more information, visit https://hoefliger.com/en/

Halozyme’s ENHANZE® drug delivery technology is based on our patented recombinant human hyaluronidase PH20 enzyme, rHuPH20, which locally degrades hyaluronan (HA) in the subcutaneous (SC) space. This allows for increased dispersion and absorption of co-administered therapies. ENHANZE technology degrades the HA around the injection site allowing large volumes (up to 300-600 mL) to be delivered in a single subcutaneous injection. Large volume injections may allow some biologics and small-molecule drugs that are administered intravenously to be delivered subcutaneously potentially providing an improved patient experience by decreasing infusion times or reducing the need for multiple injections. For more information, visit: https://halozyme.com/

For over 80 years, we have been delivering high precision injection molds for some of the most successful metered dose inhalers, insulin pens, diagnostic products and other medical drug delivery devices around the world. Our problem-solving mindset, proven track record in the healthcare industry, considerable medical experience and meticulously methodical way of working ensures you the highest quality, process control and traceability needed for your medical products. To learn more, visit www.igsgebojagema.nl

Isometric Micro Molding, a Nissha Medical Technologies Company, is a vertically integrated provider of micro molding and automated assembly solutions, with a focus on high-precision applications in the medical device and drug delivery sectors. Vertical integration enables comprehensive control over precision (controlling microns), cost and speed. 

Our expertise provides solutions tailored to various drug delivery devices. We are able to mold thin-walled components—including needle tips and cannulas—using advanced, challenging materials. This capability not only addresses the technical demands of modern drug delivery but also supports efficient production at scale, facilitating precise and reliable therapeutic delivery.

InnoCore Pharmaceuticals is a biopharmaceutical drug delivery company specialized in the development of complex parenteral sustained release formulations. By using our proprietary biodegradable polymers we can make microspheres, erodible gels and solid implants resulting in long acting and minimally invasive drug delivery products of small, medium sized (peptides) and large (proteins, antibodies) drug molecules. Learn more at www.innocorepharma.com.

Kaléo is dedicated to creating innovative healthcare solutions that help protect and empower patients. Our auto-injection technologies are protected by an extensive intellectual property portfolio of patents and meet the FDA draft guidance standard for 99.999% device reliability. Kaléo is privately-held and headquartered in Richmond, VA. Visit www.kaleo.com

Kinneir Dufort is a design and development consultancy focused on creating value through tomorrow’s delivery systems and devices. Combining expertise in engineering, user-experience and digital, we support companies globally to improve patient adherence through customized device and packaging solutions. Our experience across the entire development process helps address new challenges, deliver on business outcomes, and create user experiences that drive demand. To learn more, please visit www.kinneirdufort.com

PwC is a passionate community of solvers coming together in unexpected ways. We bring a range of capabilities to help organizations solve faster, solve more and realize more value. Across our global network of more than 284,000 people in 155 countries, we are committed to advancing quality in everything we do. To learn more, visit www.pwc.com

Slope drives operational excellence for highly complex, sample-intensive clinical trials. The platform transforms chaotic clinical trial supply chains into protocol- specific operational workflows for sponsors, CROs, clinical research sites, and labs, with a focus on sample management, clinical inventory, and data driven resupply. To learn more, please visit https://www.slope.io/